In a colon cancer mouse model, IL-6 treatment stimulated key glycolytic genes, including PFKFB3 and aerobic glycolysis, whereas the anti-IL-6R antibody decreased glycolysis [187], suggesting an important role of IL-6 in cellular metabolism. Here, IL6 is linked to colonic neoplasm.